The Watchlist: The Story Behind the Stock

The Market Online

Get the story behind the stock. The Watchlist delivers exclusive, same-day interviews with CEOs from market-moving companies around the world, moments after their news hits the wire. Cut through the noise and get the unfiltered strategy and direct insights you need to make your next move. Your new edge in the global markets is here. Subscribe now.

  1. Honey Badger Silver’s Prairie Creek Surprise: The Critical Minerals Upside | Honey Badger Silver (TSXV: TUF)

    May 19

    Honey Badger Silver’s Prairie Creek Surprise: The Critical Minerals Upside | Honey Badger Silver (TSXV: TUF)

    In this episode of The Watchlist, listeners hear from Chad Williams, Executive Chairman and CEO of Honey Badger Silver (TSXV: TUF), about the evolving opportunity at the Prairie Creek project and the emerging critical minerals upside tied to germanium and potential tungsten mineralization. The conversation explores how Prairie Creek’s silver exposure could be enhanced by strategic critical mineral potential, existing infrastructure advantages, and a renewed development strategy backed by rising silver prices and strong management alignment. This discussion covers: The strategic implications of germanium mineralization at Prairie Creek Why critical minerals could strengthen project economics Infrastructure and underground development already in place The role of silver prices in improving project attractiveness Honey Badger Silver’s vision for responsible project development This podcast is made in partnership with Honey Badger Silver. This podcast is for informational purposes only and does not constitute investment advice. Please do your own due diligence before making any investment decisions. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer #HoneyBadgerSilver #SilverStocks #CriticalMinerals #Germanium #MiningStocks #Investing #SilverMining Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    7 min
  2. DiagnosTear Targets Needle-Free Blood Testing With Eye Scan Tech | DiagnosTear Technologies (CSE: DTR)

    May 19

    DiagnosTear Targets Needle-Free Blood Testing With Eye Scan Tech | DiagnosTear Technologies (CSE: DTR)

    In this episode of The Watchlist, listeners hear from DiagnosTear Technologies Chairman Yaacov Michlin about the company’s exclusive global licensing agreement for the Clarify eye imaging platform — a technology aiming to enable blood analysis through a simple, non-invasive eye scan. The discussion explores how DiagnosTear plans to commercialize the platform, the AI and computer vision technology behind the system, and why management believes this innovation could reshape diagnostics and point-of-care healthcare worldwide. This discussion covers: DiagnosTear’s exclusive global licensing agreement for the Clarify platform How eye imaging technology could replace certain traditional blood tests The AI and computer vision technology powering the platform The commercial opportunity in point-of-care diagnostics Why management believes this could represent a major shift in healthcare testing   This podcast is made in partnership with DiagnosTear Technologies. The content is for informational purposes only and should not be considered investment advice. Please do your own due diligence before making any investment decisions. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer #DiagnosTear #DTR #Biotech #HealthcareInnovation #MedicalTechnology #Investing #PointOfCare Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    5 min

About

Get the story behind the stock. The Watchlist delivers exclusive, same-day interviews with CEOs from market-moving companies around the world, moments after their news hits the wire. Cut through the noise and get the unfiltered strategy and direct insights you need to make your next move. Your new edge in the global markets is here. Subscribe now.